Browsing byAuthorDureja, H

Jump to a point in the index:
Showing results 1 to 20 of 73  next >
Issue DateTitleAuthor(s)
2022-08Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosisVerma, N; Arora, V; Awasthi, R; Chan, Y; Jha, NK; Thapa, K; Jawaid, T; Kamal, M; Gupta, G; Liu, G; Paudel, KR; Hansbro, PM; George Oliver, BG; Singh, SK; Chellappan, DK; Dureja, H; Dua, K
2022-06-13Biomedical applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches.Kaur, J; Gulati, M; Zacconi, F; Dureja, H; Loebenberg, R; Ansari, MS; AlOmeir, O; Alam, A; Chellappan, DK; Gupta, G; Jha, NK; Pinto, TDJA; Morris, A; Choonara, YE; Adams, J; Dua, K; Singh, SK
2022-03-22Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.Shukla, SD; Shastri, MD; Vanka, SK; Jha, NK; Dureja, H; Gupta, G; Chelappan, DK; Oliver, BG; Dua, K; Walters, EH
2022-02-11Orchestration of Obesolytic Activity of Microbiome: Metabiotics at Centre Stage.Kapoor, B; Singh, A; Gulati, M; Singh, SK; Rani, P; Alzahrani, Q; Dua, K; Dureja, H; Corrie, L
2021-12-16Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions.Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S
2021-12Microfluidic chips: recent advances, critical strategies in design, applications and future perspectivesPattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V
2021-10-15Protein and peptide delivery to lungs by using advanced targeted drug delivery.Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K
2021-09Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospectsGulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H
2021-07-01Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK
2021-07-01CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeuticsBhardwaj, S; Kesari, KK; Rachamalla, M; Mani, S; Ashraf, GM; Jha, SK; Kumar, P; Ambasta, RK; Dureja, H; Devkota, HP; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Ruokolainen, J; Kamal, MA; Ojha, S; Jha, NK
2021-07Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment StrategiesAlnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK
2021-06-23Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applicationsAnand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Armugam, VA; Dua, K
2021-06-08Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases.Gulati, N; Dua, K; Dureja, H
2021-05Current-status and applications of polysaccharides in drug delivery systemsPrasher, P; Sharma, M; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Anand, K; Sharma, N; Dureja, H; Jha, NK; Gupta, G; Gulati, M; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Dua, K
2021-05Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies.Gulati, N; Kumar Chellappan, D; Tambuwala, M; A A Aljabali, A; Prasher, P; Kumar Singh, S; Anand, K; Sharma, A; Kumar Jha, N; Gupta, G; Dua, K; Dureja, H
2021-04Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: Breakthroughs and bottlenecksKaur, J; Mishra, V; Singh, SK; Gulati, M; Kapoor, B; Chellappan, DK; Gupta, G; Dureja, H; Anand, K; Dua, K; Khatik, GL; Gowthamarajan, K
2021-03-09Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infectionSingh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G
2021-02-24An overview of vaccine development for COVID-19Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM
2021-02-04Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation.Mehta, M; Paudel, KR; Shukla, SD; Shastri, MD; Satija, S; Singh, SK; Gulati, M; Dureja, H; Zacconi, FC; Hansbro, PM; Chellappan, DK; Dua, K
2021-02-04Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancerGupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K